Larimar Therapeutics, Inc. (LRMR) — Analyst estimates
Consensus analyst estimates for Larimar Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 2.49M | -0.47 | 1 |
| 2027 | 14.14M | -0.34 | 1 |
| 2028 | 152.42M | -0.57 | 5 |
| 2029 | 267.91M | -0.11 | 1 |
| 2030 | 383.41M | 0.68 | 1 |
Consensus analyst estimates by fiscal year.